tradingkey.logo
搜索

Iovance Biotherapeutics Inc

IOVA
添加自选
4.070USD
-0.620-13.22%
收盘 07-31 16:00美东报价延迟15分钟
1.82B总市值
亏损市盈率 TTM

IOVA 财务数据

通过专为投资者打造的一站式数据看板,全面查看 Iovance Biotherapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。

Iovance Biotherapeutics Inc财报日历

最新发布
8月 6, 2026
每股收益 / 预测值
--/-0.13
营业收入 / 预测值
--/87.67M
报告期
FY2025 财报
营业收入(YoY)
263.50M
60.60%
每股收益(YoY)
-1.09
14.78%
分析师评级
BUY
2026/08/02
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
财务指标
每股收益
47.50%-0.19
31.49%-0.18
9.00%-0.25
2.09%-0.33
15.22%-0.36
43.30%-0.26
40.47%-0.28
28.16%-0.34
15.54%-0.42
28.90%-0.45
---0.46
---0.47
---0.50
---0.64
----
----
----
----
----
----
营业收入
44.82%71.43M
17.74%86.77M
15.20%67.45M
92.73%59.95M
6798.46%49.32M
15189.21%73.69M
12385.07%58.55M
12969.75%31.11M
--715.00K
--482.00K
--469.00K
--238.00K
----
----
----
----
----
----
----
----
净利润
31.95%-79.05M
8.47%-71.90M
-9.23%-91.25M
-14.99%-111.66M
-2.82%-116.16M
32.50%-78.56M
26.56%-83.54M
8.85%-97.10M
-5.22%-112.98M
-10.50%-116.38M
-14.20%-113.76M
-7.23%-106.53M
-17.21%-107.37M
-6.03%-105.32M
-15.67%-99.62M
-22.12%-99.35M
-21.42%-91.61M
-45.23%-99.33M
-47.04%-86.12M
-29.09%-81.35M
利润率
53.01%-110.66%
22.27%-82.87%
5.18%-135.28%
40.34%-186.25%
98.51%-235.51%
99.56%-106.60%
99.41%-142.67%
99.30%-312.16%
---15800.84%
---24145.02%
---24255.86%
---44759.66%
----
----
----
----
----
----
----
----
毛利率
3476.94%28.55%
3.01%39.35%
-7.45%29.61%
751.14%5.48%
99.91%-0.85%
104.74%38.20%
103.88%31.99%
99.89%-0.84%
---915.52%
---805.60%
---825.37%
---761.34%
----
----
----
----
----
----
----
----
资产负债率
4.44%0.11%
-0.30%0.11%
9.51%0.11%
6.27%0.11%
-10.02%0.10%
-14.29%0.11%
-14.00%0.10%
-21.47%0.10%
-5.19%0.11%
-14.91%0.13%
--0.12%
--0.13%
--0.12%
--0.15%
----
----
----
----
----
----
营业收入
44.82%71.43M
17.74%86.77M
15.20%67.45M
92.73%59.95M
6798.46%49.32M
15189.21%73.69M
12385.07%58.55M
12969.75%31.11M
--715.00K
--482.00K
--469.00K
--238.00K
----
----
----
----
----
----
----
----
营业利润
33.14%-81.04M
7.22%-73.46M
-0.78%-89.76M
-11.64%-113.77M
-2.97%-121.22M
34.70%-79.18M
24.75%-89.07M
7.42%-101.91M
-6.19%-117.72M
-13.29%-121.26M
-17.90%-118.36M
-10.38%-110.09M
-20.87%-110.86M
-7.61%-107.04M
-16.41%-100.39M
-22.48%-99.73M
-21.36%-91.71M
-45.85%-99.47M
-46.26%-86.24M
-27.97%-81.43M
净利润
31.95%-79.05M
8.47%-71.90M
-9.23%-91.25M
-14.99%-111.66M
-2.82%-116.16M
32.50%-78.56M
26.56%-83.54M
8.85%-97.10M
-5.22%-112.98M
-10.50%-116.38M
-14.20%-113.76M
-7.23%-106.53M
-17.21%-107.37M
-6.03%-105.32M
-15.67%-99.62M
-22.12%-99.35M
-21.42%-91.61M
-45.23%-99.33M
-47.04%-86.12M
-29.09%-81.35M
流动资产
-9.00%466.50M
-3.14%442.69M
-13.94%429.09M
-12.39%422.50M
32.97%512.65M
48.46%457.02M
30.32%498.58M
75.44%482.26M
-39.55%385.53M
-35.75%307.85M
3.43%382.59M
-36.31%274.88M
30.17%637.78M
-5.68%479.12M
-36.56%369.88M
-35.26%431.59M
-19.04%489.97M
-20.15%507.96M
-19.43%583.03M
-14.82%666.64M
流动负债总额
5.48%129.42M
13.09%138.36M
6.55%125.78M
37.93%129.16M
47.44%122.69M
10.91%122.34M
29.80%118.06M
5.64%93.64M
-4.65%83.21M
20.57%110.31M
14.78%90.95M
38.09%88.64M
13.23%87.27M
2.56%91.48M
22.36%79.25M
6.04%64.19M
39.99%77.08M
62.56%89.20M
0.58%64.77M
10.25%60.53M
总资产
-4.25%925.66M
0.30%913.17M
-8.69%904.95M
-5.90%907.44M
11.14%966.74M
16.67%910.43M
16.29%991.12M
27.34%964.32M
5.46%869.83M
17.53%780.35M
56.12%852.32M
23.97%757.29M
17.61%824.77M
-14.58%663.98M
-34.13%545.92M
-28.37%610.88M
-6.57%701.25M
1.15%777.33M
5.95%828.83M
4.31%852.79M
总负债
2.53%203.91M
7.28%214.59M
-6.89%202.66M
6.73%208.95M
4.78%198.88M
2.19%200.02M
22.07%217.66M
9.54%195.78M
20.22%189.81M
19.10%195.74M
17.16%178.31M
29.33%178.72M
5.78%157.89M
5.57%164.34M
16.62%152.19M
27.51%138.19M
44.71%149.26M
39.04%155.67M
85.22%130.50M
82.89%108.38M
总权益
-6.01%721.75M
-1.66%698.58M
-9.20%702.29M
-9.11%698.49M
12.92%767.87M
21.52%710.40M
14.75%773.46M
32.83%768.54M
1.97%680.02M
17.01%584.61M
71.18%674.01M
22.40%578.57M
20.81%666.88M
-19.63%499.64M
-43.62%393.74M
-36.50%472.69M
-14.74%551.99M
-5.31%621.66M
-1.90%698.33M
-1.83%744.41M
经营净额
30.49%-72.07M
28.28%-52.56M
-33.45%-78.70M
31.48%-67.45M
15.20%-103.69M
12.71%-73.30M
29.86%-58.97M
-4.77%-98.43M
-22.51%-122.28M
-8.11%-83.97M
-32.10%-84.08M
-21.02%-93.95M
-35.25%-99.81M
-44.24%-77.67M
-10.32%-63.65M
-43.75%-77.64M
-18.29%-73.80M
14.11%-53.85M
-42.40%-57.69M
-47.42%-54.01M
投资净额
-28.19%11.39M
-96.73%775.00K
134.86%17.01M
-65.58%13.84M
114.23%15.87M
132.50%23.68M
38.24%-48.80M
125.65%40.22M
-172.69%-111.51M
-15901.52%-72.84M
-207.19%-79.01M
-263.72%-156.78M
77.30%153.40M
-99.34%461.00K
478.25%73.72M
160.17%95.76M
12.05%86.52M
18.02%69.34M
124.07%12.75M
62.44%-159.16M
融资净额
-34.18%94.33M
2332.74%56.17M
109.89%88.06M
-91.34%13.23M
-25.96%143.31M
140.02%2.31M
-79.31%41.95M
14809.76%152.82M
-25.02%193.58M
-99.50%962.00K
90033.33%202.80M
149.59%1.02M
18119.62%258.17M
4492.17%190.57M
-98.92%225.00K
-101.26%-2.07M
-97.19%1.42M
40.30%4.15M
1681.48%20.77M
-71.15%163.98M

常见问题

Iovance Biotherapeutics Inc的总收入是多少?

根据Iovance Biotherapeutics Inc的FY2025财报,总收入达到了263.50M(同比变化164.07M)。

Iovance Biotherapeutics Inc的流动资产是多少?

根据Iovance Biotherapeutics Inc的FY2025财报,流动资产为442.69M(同比变化-3.14)。

Iovance Biotherapeutics Inc的总资产是多少?

根据Iovance Biotherapeutics Inc的FY2025财报,Iovance Biotherapeutics Inc的总资产为913.17M(同比变化0.30)。

Iovance Biotherapeutics Inc的总负债是多少?

根据Iovance Biotherapeutics Inc的FY2025财报,Iovance Biotherapeutics Inc的总负债为214.59M(同比变化7.28)。

Iovance Biotherapeutics Inc的总权益是多少?

根据Iovance Biotherapeutics Inc的FY2025财报,Iovance Biotherapeutics Inc的总权益为698.58M(同比变化-1.66)。

Iovance Biotherapeutics Inc的净营业收入是多少?

根据Iovance Biotherapeutics Inc的FY2025财报,Iovance Biotherapeutics Inc的净营业收入为-398.21M(同比变化-2.66)。

Iovance Biotherapeutics Inc的净投资是多少?

根据Iovance Biotherapeutics Inc的FY2025财报,Iovance Biotherapeutics Inc的净投资为47.50M(同比变化149.26)。

Iovance Biotherapeutics Inc的净融资是多少?

根据Iovance Biotherapeutics Inc的FY2025财报,Iovance Biotherapeutics Inc的净融资为300.77M(同比变化-23.01)。

Iovance Biotherapeutics Inc的每股收益(EPS)是多少?

根据Iovance Biotherapeutics Inc的FY2025财报,每股收益(EPS)为-1.09(同比变化14.78)。

Iovance Biotherapeutics Inc的净利润是多少?

根据Iovance Biotherapeutics Inc的FY2025财报,净利润为-390.98M(同比变化-5.05)。

Iovance Biotherapeutics Inc的净利润率是多少?

根据Iovance Biotherapeutics Inc的FY2025财报,净利润率为-148.38(同比变化34.59)。

Iovance Biotherapeutics Inc的毛利率是多少?

根据Iovance Biotherapeutics Inc的FY2025财报,毛利率为20.64(同比变化-15.51)。

Iovance Biotherapeutics Inc的债务与资产比率是多少?

根据Iovance Biotherapeutics Inc的FY2025财报,债务与资产比率为0.11(同比变化-0.30)。

Iovance Biotherapeutics Inc的股东权益回报率(ROE)是多少?

根据Iovance Biotherapeutics Inc的FY2025财报,股东权益回报率(ROE)为-55.50(同比变化3.45)。

Iovance Biotherapeutics Inc的资产回报率(ROA)是多少?

根据Iovance Biotherapeutics Inc的FY2025财报,资产回报率(ROA)为-42.88(同比变化2.60)。

Iovance Biotherapeutics Inc的营业利润是多少?

根据Iovance Biotherapeutics Inc的FY2025财报,营业利润为-398.21M(同比变化-2.66)。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有